FEBBO PHILLIP G. (Chief Scientific & Med Officer) sold 9.0% of their position (13.11K shares) of VERACYTE, INC. on the open market
Open‑market sale worth $564.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/4/2026ACC: 0001649245-26-000009
Officer· Chief Scientific & Med Officer
Since Mar 2026
-16.75K
Net shares
Net seller
$727.7K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
16.75K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.64K
Price / share
$44.88
Trade value
$163.32K
% of position
2.4%
9/2/2026
149.80K→146.16K
Common Stock
Direct
Shares
−10.40K
Price / share
$42.89
Trade value
$446.30K
% of position
7.1%
9/4/2026
146.16K→135.75K
Common Stock
Direct
Shares
−2.71K
Price / share
$43.66
Trade value
$118.11K
% of position
2.0%
9/4/2026
135.75K→133.05K
Total
Net shares
−16.75K
Net value
-$727.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −3.64K | $44.88 | $163.32K | 2.4% | 149.80K | 146.16K |
| Common Stock Direct | 9/4/2026 | S · Sale | −10.40K | $42.89 | $446.30K | 7.1% | 146.16K | 135.75K |
| Common Stock Direct | 9/4/2026 | S · Sale | −2.71K | $43.66 | $118.11K | 2.0% | 135.75K | 133.05K |
| Total | −16.75K | -$727.73K | ||||||
Derivative Transactions0
No derivative transactions reported